Article
HLA-DPB1*13:01 associates with enhanced, and KIR2DS4*001 with diminished protection from developing severe COVID-19.
HLA - 1 Jan 2024
Farias Ticiana D J, Brugiapaglia Silvia, Croci Susanna, Magistroni Paola, Curcio Claudia, Zguro Kristina, Fallerini Chiara, Fava Francesca, Pettini Francesco, Kichula Katherine M, Pollock Nicholas R, Font-Porterias Neus, Palmer William H, Marin Wesley M, Baldassarri Margherita, Bruttini Mirella, Hollenbach Jill A, Hendricks Audrey E, Meloni Ilaria, Novelli Francesco, Renieri Alessandra, Furini Simone, Norman Paul J, Amoroso Antonio
Abstract excerpt
Extreme polymorphism of HLA and killer-cell immunoglobulin-like receptors (KIR) differentiates immune responses across individuals. Additional to T cell receptor interactions, subsets of HLA class I act as ligands for inhibitory and activating KIR, allowing natural killer (NK) cells to detect and...
Topics
- Humans
- COVID-19
- SARS-CoV-2
- Alleles
- Receptors, KIR
- Genotype
- Autoantibodies
- HLA-DP beta-Chains
